Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Radiation Therapy with Bevacizumab and Chemotherapy in High-Risk NSCLC
NCT00387374Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Oct 2006
- Primary completion
- Jun 2007
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of bevacizumab in non-small cell lung cancer (NSCLC), sponsored by National Cancer Institute. Started Oct 2006; status: completed.
02
Drugs
bevacizumab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00387374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00387374.